Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001654954-24-012786
Filing Date
2024-10-08
Accepted
2024-10-08 17:13:11
Documents
13

Document Format Files

Seq Description Document Type Size
1 S-3/A cvm_s3a.htm S-3/A 251684
2 LEGAL OPINION cvm_ex5.htm EX-5 8693
3 CONSENT cvm_ex231.htm EX-23.1 2721
4 CONSENT cvm_ex232.htm EX-23.2 2843
5 FILING FEE TABLES cvm_ex107.htm EX-FILING FEES 30069
6 cvm_s3aimg9.jpg GRAPHIC 22106
7 cvm_s3aimg16.jpg GRAPHIC 43398
8 cvm_s3aimg15.jpg GRAPHIC 22789
9 cvm_s3aimg14.jpg GRAPHIC 17537
10 cvm_s3aimg13.jpg GRAPHIC 46924
11 cvm_s3aimg12.jpg GRAPHIC 30445
12 cvm_s3aimg11.jpg GRAPHIC 19839
13 cvm_s3aimg10.jpg GRAPHIC 22045
  Complete submission text file 0001654954-24-012786.txt   608052
Mailing Address 8229 BOONE BLVD. SUITE 802 VIENNA VA 22182
Business Address 8229 BOONE BLVD . SUITE 802 VIENNA VA 22182 7035069460
CEL SCI CORP (Filer) CIK: 0000725363 (see all company filings)

EIN.: 840916344 | State of Incorp.: CO | Fiscal Year End: 0930
Type: S-3/A | Act: 33 | File No.: 333-265995 | Film No.: 241360930
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)